Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here you are, "worry":
"If there is a settlement (pray for it to happen soon), I would hope DECN does not do confidential settlement with JNJ."
"I have to admit that I start to worry about DECN ability to survive if not settled soon."
And your worry has what to do with wanting public release of settlement information?
"If there is a settlement (pray for it to happen soon)"
Why soon? Court cases settle when they settle. I am sure DECN management can contact JnJ management and offer their surrender because some DECN small shareholders are antsy. That could get the job done "soon." Is that what you want? And what do you expect DECN to get from this hurried settlement?
"I would hope DECN does not do confidential settlement with JNJ."
I am not an expert in these matters, but typically the guy who pays the money in a settlement is the guy who calls the shots in regards to exposure. Do you believe JnJ wants the world to know that they had to pay settlement dollars to a small company?
"I don't read PACER so everything I've read on here COULD be biased but with the Solicitor General on DECN's side I'd have to assume posters are correct claiming DECN is winning in court."
I have found that the beating of drums on this and other message boards regarding the facts and informed speculation in this JnJ case is rarely biased. Rather, I have found, it is typically understated. IMO
"Has there been any indication from the company and/or the court filings as to an amount that both sides are looking to settle at?"
New to the legal game? Companies don't publish the amount they are seeking, and unless there is a verdict, which is public information, and companies do not announce what they have received in confidential settlements.
This is the Solicitor's conclusion?
"Embarrassing. Par for the DECN course though."
Embarrassing for who? Shareholders?
A little heart flutter today. :)
And the Solicitor did file those briefs and you know what he concluded? J&J is "sandbagging."
"This baby is looking and cooking to pop! PSID!"
Add in another $1.51 and I will be back to even.
I was wondering if anyone saw the newest product offering on the web site? Things are going well here at this DECN.
http://pharmatechdirect.com/products.html bottom of the page
And that's a big "oh well" little buddy.
All IMHO
Big day today. A new Mod -- great. The message board was upgraded -- thank you Cakes. And, the legal papers were filed, which have to be very dangerous for JnJ.
My understanding is that the legal briefs become public documents within minutes of them being filed. But, you need a private subscription to the Federal PACER to read the filings.
I for one would like to hear answer to this.
"So please explain to me, how then DECN shareholders would have benefitted without being financed in this 3 years Long struggle? By closing the Business?"
I think it is wonderful that you stay on top of the events. Anyone could have made the same mistake. But, the company did another asset deal through Alpha (Anstalt) in late March. They appear to be "go-to" guys. In small company finance a "go-to" guy is good to have.
Also to save space and time, I am informed that there are no hearings planned for this week in the JnJ case, only filing dates. And in any event, the case now being fought over (with big time Fortune 25 losses) is in Washington, DC not California.
This is a seek and ye shall find moment.
Alpha Capital Anstalt is a different entity with different ownership than Alpha Credit Resources.
Alpha Capital Anstalt is a family owned fund out of, I believe Austria, but managed in the U.S. I am aware of several of their investments
More importantly, there is probably not a single CPA working for Alpha that distrusts the market, nor is there a single trader at Alpha trading for his own account. This is great for DECN. Some can look at the as the judicious use of bottomless funding. IMHO
Company M&A is very different than trading of stock shares. Companies often do not use their cash reserves to make acquisitions or investments, so they bring in experts who do this for them. The expert, in this case an SEC registered fund, fronted the money to DECN to make the investment in Korea. The value of the investment was $275,000 and the transaction pushed out the payback to the fund for 18 months. Since all investments are about putting money to work, the DECN investment has 18 months to perform.
Good for longs, and if stock traders gave it any thought, it is good for them too.
Thank you for the cheery news on Saturday morning.
"You think people are selling on news here??"
I do, otherwise what could explain the sideways trading of the stock and places like here where news and more news is requested. I don't trade stocks and I was asked for speculation, so I provided my take.
"why do you suppose investor reaction to the latest two announcements resulted in a share price that is trending lower, not spiking higher? Or does share price not figure into your perspective?"
I have no idea why share price trended lower but I can speculate. It might be that there are more sell on news people than buy on good news people. It might be that there are a significant number of traders in this stock that if the stock is going sideways they want to sell and recapture dead money.
As for whether share price enters into my equation, all I can say is that share price is more a part of my equation than the litigation trend and the business path to success appear to be a part of yours.
Thank you for educating me. You won't mind if I seek other opinions?
I never second guess management. Why would I tell management I am disappointed and I don't trust them and their news releases are feeble when I do not walk in their shoes. Unless shareholders replace management and the Board they are all we as shareholders have. I have noticed for the first time that a lot of what is posted here is of a tactical nature (press release driving share price). What would make you believe that every press release is tactical? I personally do not know one way or another but management at DECN is seasoned and from the industry they compete in. I would expect them to have a strategic view and from time to time put out strategic news releases.
As an aside, management bashing could lead to the exact opposite of what you are trying to accomplish. Telling management that they stink will make them think twice about the intentions of small shareholders.
This management team did not buy the J&J lawsuit but they are fighting and winning. That is a much bigger accomplishment then a few more short term cents per share.
GLTY
"At the close of the review of our OTCQX application, DECN will host a conference call to inform our shareholders and others in the investment community of the company's progress and our plans for the near future"
That above is what the company said in a May press release. You obviously are not happy with that statement because you are now saying that the company has lost credibility by not doing something they never agreed to do in the first place.
No patience.
I read that press release. I cannot yet see where management is is not doing what they indicated in the press release. Patience, patience.
That is an interesting contrarian take on things. IMO DECN stock rockets the moment a victory is announced, even if the terms of the victory are sealed. A small company defeating JnJ fall into the "man bites dog" category.
Class II medical devices do not need FDA approval for private label arrangements. Class II medical devices fall under the FDA Modifications Guidance from 1996. No significant changes to the device, then register the name addition, if any, to the main device registration and move on.
"Premarket approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices. Class III devices are those that support or sustain human life, are of substantial importance in preventing impairment of human health, or which present a potential, unreasonable risk of illness or injury.
I am sorry. I must be totally dumb. I just don't understand the significance of posting two contracts and a state drug distribution license from 2005. Wasn't that DECN's business in those days, medical products distribution. I must be missing something.
"There have only been a couple of hearings. I would assume that DECN's bills are considerably higher, relatively speaking."
There have been 76 hearings and conferences since September 2011 and almost 500 separate filings. Of the 76 hearings, 67 of them are the result of J&J actions. Anyone who knows anything about complex litigation knows that the moving party in any action spends between 6 and 10 times the party defending. So, on 67 occasions J&J spent at least 8 times more than DECN.
Does that sound like a good investment given where J&J stands in this patent litigation. Below is a link you can follow and seek and ye shall find.
https://dockets.justia.com/docket/california/candce/5:2011cv04494/246240/
I would assume that J&J's legal bills are outrageously high. In retrospect I believe this case could have been settled for much less. Now it may be too late for that.
I always defer to someone with more knowledge. I would however like to know how you know.
JnJ's business base has been declining and they have reported this in their last 9 public filings. It appears to be averaging 2.5% per quarter. To protect what is left of that base, companies in JnJ's position raise prices to maintain total margin dollars. This is why generics come into the market when companies' star products get to the other side of the product life cycle curve.
"Being that the '105 patent is Lifescan's most important patent for glucose, if their patent is extinguished, will they have to sell the glucose meter business?"
If they lose their monopoly protection by losing the patent, doesn't JnJ become just another glucose test supplier? Aren't there about 100 other providers? And if that patent is lost, how much is the glucose business worth above its already declining business base?
Why are you in this stock with all of those other winners?
Still nothing from MOBQ.
Isn't this week the big week in the JNJ--DECN legal case?
Do you know the name of this Korean company? Not that it matters, but I am curious and would like to hear it from you.
The number of posters who do not believe that the company has signed a Korean contract is very small. Perhaps these people could call the company, schedule a time to visit the company's offices and ask to see the contract. I believe that in order to accomplish this, you only need to prove that you are a shareholder. Make this visit, review the contract and then come back and report. I for one would appreciate a fair and balanced report.
I have seen this goodness on scoreboards and message boards at stadiums and arenas, but never on an Internet message board. How very nice. Congrats!
Korea is a virtual client state of the U.S. Taiwan is a part of the older axis of technological powers including Israel and formerly South Afrika.
An R&D deal where the U.S. company specifies the product, and the Koreans or Taiwanese build it is not only how deals in this decade work. It may be a dagger into the heart of the former champion. IMO
nealg I have no reason to think otherwise and I may still be totally off base, but I believe this proposed mediation is nothing more than a continuation of the fireworks mediations of January and February 2015 and may mean very little for everyone except Mr. Berman who has to be around in case someone fires off a cherry bomb, or sends up a flare. I also believe that JnJ may be tiring of DECN's news releases that are stabs at Lifescan's gut.
Whenever the other side downplays significance of something such as writing "DECN is but a gnat and the effect on JnJ is non-existent" tells me that DECN is more likely a tze-tze fly, small but poisonous, biting at JnJ every day. Why would a Fortune 25 company feel the need to use message board posters to protect their downside from a gnat?